![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Littlewood J.M. Wolfe S.P.
Publisher: Adis International
ISSN: 1174-5878
Source: Pediatric Drugs, Vol.2, Iss.3, 2000-05, pp. : 205-222
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug Disposition in Cystic Fibrosis
By Rey E. Tréluyer J-M. Pons G.
Clinical Pharmacokinetics, Vol. 35, Iss. 4, 1998-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Nebulized Antibiotics in Cystic Fibrosis
Pediatric Drugs, Vol. 4, Iss. 7, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Non-cystic fibrosis bronchiectasis
Clinical Medicine, Vol. 9, Iss. 2, 2009-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Na + in cystic fibrosis: is it important?
Trends in Pharmacological Sciences, Vol. 16, Iss. 4, 1995-04 ,pp. :